Nomura Holdings’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-237,500
Closed -$16.8M 1527
2022
Q3
$16.8M Buy
+237,500
New +$18.6M 0.07% 221
2020
Q3
Sell
-110,000
Closed -$8.05M 1327
2020
Q2
$8.05M Sell
110,000
-210,000
-66% -$14.9M 0.03% 308
2020
Q1
$21.5M Buy
+320,000
New +$22.6M 0.09% 123
2017
Q1
Sell
-30,000
Closed -$1.97M 1323
2016
Q4
$1.97M Hold
30,000
0.01% 864
2016
Q3
$2.22M Hold
30,000
0.01% 646
2016
Q2
$2.19M Hold
30,000
0.01% 639
2016
Q1
$2.12M Buy
+30,000
New +$2M 0.01% 556
2015
Q1
Sell
-56,100
Closed -$3.88M 1824
2014
Q4
$3.88M Sell
56,100
-3,200
-5% -$216K 0.01% 719
2014
Q3
$3.89M Buy
59,300
+53,800
+978% +$3.55M 0.01% 795
2014
Q2
$375K Hold
5,500
﹤0.01% 1976
2014
Q1
$356K Buy
+5,500
New +$347K ﹤0.01% 1975

Other funds holding CL

Nomura Holdings's CL Position: Q2 2026 in Review

Nomura Holdings increased its Colgate-Palmolive (CL) stake by 1,653% in Q2 2026, buying an estimated $3.95M and bringing the position to 47,869 shares worth $4.39M. The position accounts for 0.01% of the portfolio, ranked #839.

Nomura Holdings first reported a position in CL in Q2 2013 and has held it in 49 quarters since. The position peaked at $32.8M in Q3 2020. 2,021 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Nomura Holdings held 47,869 shares of Colgate-Palmolive worth $4.39M as of Q2 2026.
  • Nomura Holdings bought 45,138 Colgate-Palmolive shares in Q2 2026, an estimated $3.95M.
  • Colgate-Palmolive made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #839 holding.
  • Nomura Holdings first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 49 quarters since.
  • Nomura Holdings's Colgate-Palmolive position peaked at $32.8M in Q3 2020.
  • 2,021 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.